Assignee
ANTIGEN EXPRESS INC
US·8 granted patents·5 pending applications·150 citations·filing 1993–2014
Top patents by PatentIndex Score
13 records- 0191US7179645B2Ii-Key/antigenic epitope hybrid peptide vaccinesANTIGEN EXPRESS INC·Filed 2002·Granted Feb 20, 2007·54 cites·8 claims
- 0287US7935350B2Ii-key/Her-2/neu hybrid cancer vaccineANTIGEN EXPRESS INC·Filed 2007·Granted May 3, 2011·4 cites·4 claims
- 0382US7541334B2Hybrid peptides modulate the immune responseANTIGEN EXPRESS INC·Filed 2007·Granted Jun 2, 2009·3 cites·1 claims
- 0478US5559028AMethods of enhancing or antigen presentation to T cells inhibitingANTIGEN EXPRESS INC·Filed 1993·Granted Sep 24, 1996·37 cites·3 claims
- 0577US7205274B2Hybrid peptides modulate the immune responseANTIGEN EXPRESS INC·Filed 2002·Granted Apr 17, 2007·6 cites·3 claims
- 0671US6432409B1Hybrid peptides modulate the immune responseANTIGEN EXPRESS INC·Filed 1999·Granted Aug 13, 2002·24 cites·6 claims
- 0764US2015093402A1Ii-KEY/HER-2/NEU HYBRID CANCER VACCINEANTIGEN EXPRESS INC·Filed 2014·Application pending·0 cites
- 0856US6368855B1MHC class II antigen presenting cells containing oligonucleotides which inhibit Ii protein expressionANTIGEN EXPRESS INC·Filed 1998·Granted Apr 9, 2002·11 cites·39 claims
- 0955US2008305122A1Ii-Key/antigenic epitope hybrid peptide vaccinesANTIGEN EXPRESS INC·Filed 2007·Application pending·0 cites
- 1052US5679527AModification of polypeptide structureANTIGEN EXPRESS INC·Filed 1994·Granted Oct 21, 1997·11 cites·1 claims
- 1149US2003235594A1Ii-Key/antigenic epitope hybrid peptide vaccinesANTIGEN EXPRESS INC·Filed 2002·Application pending·0 cites
- 1248US2003198626A1Inhibition of Ii expression in mammalian cellsANTIGEN EXPRESS INC·Filed 2002·Application pending·0 cites
- 1346US2003054365A1MHC class II antigen presenting cells containing oligonucleotides which inhibit Ii protein expressionANTIGEN EXPRESS INC·Filed 2002·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →